MYC and cancer: Although Zagani et al. [43] demonstrated that Eμ-Myc transgenic mouse model was not the correct model to conduct studies on G0S2, they found deletion of the G0S2 gene in mice did not show any effect on the latency of cancer progression in the Eμ-Myc model of lymphoma [43].